Testbiotech Background: Comment on EFSA draft document on risk assessment of plants developed with Type 1 (SDN-1) and Type 2 (SDN-2) site-directed nucleases and oligonucleotide directed mutagenesis (ODM) (May 2020)

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.